Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
J Appl Glycosci (1999) ; 63(3): 69-75, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-34354485

RESUMEN

A spherical gel containing amino groups was prepared using monomers of N,N-dimethylacrylamide and N,N-dimethylaminoethyl methacrylate, with a cross-linker composed of N,N'-methylenebisacrylamide prepared by suspension polymerization for the adsorption of glucuronic acid and chondroitin sulfate. The prepared gel was immersed in glucose, glucuronic acid, and chondroitin sulfate solutions to determine the adsorption performance in batch mode, which demonstrated that 20 % of the chondroitin sulfate was adsorbed to the amino-group-containing gel. The amino-group-containing gel was packed into a column to permeate the chondroitin sulfate-containing solution (0.40 g/L) at pH 2.0, and it adsorbed chondroitin sulfate to the gel at a space velocity of 4.5 h-1. When the space velocity was changed to 1.5 h-1, the amount of chondroitin sulfate increased. When 0.50 M NaCl solution was permeated through the chondroitin-sulfate-adsorbed gel in column mode, 70 % of the chondroitin sulfate was eluted. This spherical gel may be applicable for acidic glycan recovery using batch and permeation modes.

2.
Enzyme Res ; 2011: 896567, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21755044

RESUMEN

Recent observations on environment-linked control of genetically prescribed signaling systems for either cell activation or cell death have been reviewed with a focus on the regulation of activities of protein tyrosine kinases (PTKs). The environment-linked redox reactions seem to primarily affect cell surface receptors and cell membrane lipid rafts, and they induce generation of reactive oxygen species (ROS) in cells. ROS thus generated might upregulate the catalytic activities of PTKs through inactivating protein tyrosine phosphatases that dephosphorylate and inactivate autophosphorylated PTKs. Recent evidence has, however, demonstrated that ROS could also directly oxidize SH groups of genetically conserved specific cysteines on PTKs, sometimes producing disulfide-bonded dimers of PTK proteins, either for upregulation or downregulation of their catalytic activities. The basic role of the redox reaction/covalent bond-mediated modification of protein tertiary structure-linked noncovalent bond-oriented signaling systems in living organisms is discussed.

3.
J Cell Biochem ; 108(5): 1059-65, 2009 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-19830705

RESUMEN

Although methane sulfonate compounds are widely used for the protein modification for their selectivity of thiol groups in proteins, their intracellular signaling events have not yet been clearly documented. This study demonstrated the methane sulfonate chemical 1,4-butanediyl-bismethanethiosulfonate (BMTS)-induced cascades of signals that ultimately led to apoptosis of Jurkat cells. BMTS induced apoptosis through fragmentation of DNA, activation of caspase-9 and caspase-3, and downregulation of Bcl-2 protein with reduction of mitochondrial membrane potential. Moreover, BMTS intensely and transiently induced intracellular reactive oxygen species (ROS) production and ROS produced by BMTS was mediated through mitochondria. We also found that a reducing agent dithiothreitol (DTT) and an anti-oxidant N-acetyl cysteine (NAC) inhibited BMTS-mediated caspase-9 and -3 activation, ROS production and induction of Annexin V/propidium iodide double positive cells, suggesting the involvement of ROS in the apoptosis process. Therefore, this study further extends our understanding on the basic mechanism of redox-linked apoptosis induced by sulfhydryl-reactive chemicals.


Asunto(s)
Apoptosis/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Ácidos Tiosulfónicos/farmacología , Acetilcisteína/farmacología , Apoptosis/fisiología , Caspasa 3/metabolismo , Caspasa 9/metabolismo , Fragmentación del ADN/efectos de los fármacos , Ditiotreitol/farmacología , Depuradores de Radicales Libres/farmacología , Humanos , Células Jurkat , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Potencial de la Membrana Mitocondrial/fisiología , Mitocondrias/metabolismo , Oxidación-Reducción , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología
4.
Apoptosis ; 13(4): 523-30, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18297401

RESUMEN

Vinorelbine is a chemotherapeutic vinca alkaloid clinically prescribed for non-small cell lung cancer and breast cancer. Here we studied the mechanism for vinorelbine-induced apoptosis in a human T-cell lymphoma. Although vinorelbine induces DNA fragmentation that is inhibited by specific peptide inhibitors for caspases-9 and -3 in Jurkat cells, caspase-8 deficiency retards vinorelbine-induced apoptosis. Activation of caspase-8 is also observed in vinorelbine-treated cells, and the activity is diminished when the caspase-3 activity is blocked by a specific peptide inhibitor, Ac-DNLC-CHO. Blocking of the Fas receptor with an antagonistic anti-Fas antibody does not affect vinorelbine-induced DNA fragmentation. These results suggest that vinorelbine-induced apoptosis is enhanced by the activation of caspase-8 via caspase-9-mediated activation of caspase-3, but not through a Fas-triggered signal. Western blotting suggests that vinorelbine cleaves caspase-3, -9 and -8 and reduces the amount of mitochondrial cytochrome c. Caspase-8 deficiency suppresses all of these events. A downstream substrate for caspase-8, Bid, is also cleaved in vinorelbine-treated cells, but the Bid truncation is also observed in caspase-8-deficient Jurkat cells. Importantly, recombinant caspases-3 and -9, as well as caspase-8, directly cleaves recombinant Bid in vitro. These results suggest that caspases-3 and -9 participate in Bid truncation, indicating a new mechanism for vinorelbine-induces apoptosis.


Asunto(s)
Apoptosis/efectos de los fármacos , Proteína Proapoptótica que Interacciona Mediante Dominios BH3/metabolismo , Caspasa 3/fisiología , Caspasa 9/fisiología , Linfoma de Células T/tratamiento farmacológico , Vinblastina/análogos & derivados , Caspasa 8/fisiología , Línea Celular Tumoral , Citocromos c/metabolismo , Humanos , Células Jurkat , Linfoma de Células T/patología , Vinblastina/farmacología , Vinblastina/uso terapéutico , Vinorelbina
5.
J Invest Dermatol ; 127(5): 1244-9, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17159911

RESUMEN

Recently, we crossed an original haired RET-transgenic mouse of line 242 with a hairless mouse and established a hairless RET-(HL/RET)-transgenic mouse line (242-hr/hr) with hyperpigmented skin but no tumors. In this study, we examined the effect of hyperpigmented skin in HL/RET-transgenic mice on UV irradiation-mediated cutaneous cancer development. UV irradiation to this mouse line never induced melanoma despite the presence of melanoma-inducible transgenic RET oncogenes. On the contrary, the hyperpigmented skin efficiently protected UV-mediated squamous carcinoma development in the skin. Probably underlying this result, hyperpigmentation protected the skin from damage and blocked the accompanying signal transduction for tyrosine phosphorylation of multiple cellular proteins and activation/phosphorylation of extracellular signal-regulated, c-Jun N-terminal, and p38 kinases. Thus, we demonstrated hyperpigmentation-mediated in vivo protection against UV irradiation-induced skin cancer.


Asunto(s)
Hiperpigmentación/fisiopatología , Melanoma/prevención & control , Neoplasias Inducidas por Radiación/prevención & control , Neoplasias Cutáneas/prevención & control , Rayos Ultravioleta/efectos adversos , Animales , Melaninas/genética , Melaninas/fisiología , Melanoma/genética , Melanoma/patología , Ratones , Ratones Pelados , Ratones Transgénicos , Neoplasias Inducidas por Radiación/genética , Proteínas Proto-Oncogénicas c-ret/genética , Proteínas Proto-Oncogénicas c-ret/fisiología , Transducción de Señal/genética , Transducción de Señal/fisiología , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/patología
7.
FEBS Lett ; 580(3): 839-43, 2006 Feb 06.
Artículo en Inglés | MEDLINE | ID: mdl-16427628

RESUMEN

The cysteine in the M/IXXCW motif is conserved in all but one (threonine in place of cysteine) of the human protein tyrosine kinases (PTKs). We showed that all RET-PTC-1 mutants in which the C in this motif (C376) was replaced with glycine, lysine, threonine or serine lost their activity in vitro. However, the C376T/S mutants showed normal tyrosine phosphorylation in vivo (in cells). Further analyses reveled that protein kinase C (PKC) initiated the activities of the C376T/S mutants in cells. We conclude that the M/IXXCW motif-mediated mechanisms which initiate PTK activities are partially replaced by a PKC-mediated mechanism.


Asunto(s)
Sustitución de Aminoácidos/genética , Proteína Quinasa C/genética , Proteínas Tirosina Quinasas/genética , Secuencias de Aminoácidos/genética , Animales , Humanos , Ratones , Células 3T3 NIH
8.
Am J Pathol ; 166(3): 831-41, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15743795

RESUMEN

Interleukin (IL)-6 is a pleiotropic cytokine that has been shown to inhibit the growth of early stage and to promote the proliferation of advanced stage melanoma cells in vitro. In patients with metastasizing melanomas, highly increased IL-6 blood levels correlate with a poor response to chemotherapy and a worse overall prognosis, suggesting that IL-6 promotes melanoma progression in vivo. Here, we analyzed the role of IL-6 in melanoma development and progression in a transgenic mouse model. We bred IL-6-deficient mice with MT-ret transgenic animals predisposed for melanomas. While MT-ret transgenic animals develop severe melanosis of the skin and subcutis and subsequent melanomas at an incidence of 80% during their first year of life, MT-ret mice devoid of IL-6 developed preneoplastic melanosis and consecutive melanomas significantly less frequently (47%; P < 0.05). Moreover, the tumors were significantly smaller in the groups of MT-ret mice lacking one (P < 0.05) or both (P < 0.01) copies of the IL-6 gene. Immunoblot analysis revealed that ret transgene expression was not reduced in the skin of mice lacking IL-6, indicating that the observed decrease of melanoma incidence and of tumor sizes was not because of a down-regulation of transgene expression. Taken together, these results indicate that IL-6 enhances both the development of melanoma precursor lesions and the subsequent growth of the resulting tumors in the MT-ret model of melanoma development.


Asunto(s)
Interleucina-6/genética , Interleucina-6/fisiología , Melanoma/genética , Neoplasias Cutáneas/genética , Animales , Biopsia , Western Blotting , Técnicas de Cultivo de Célula , Citocinas/metabolismo , Proteínas de Unión al ADN/metabolismo , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Regulación hacia Abajo , Genotipo , Immunoblotting , Inmunohistoquímica , Inflamación , Interleucina-6/metabolismo , Lectinas/metabolismo , Sistema de Señalización de MAP Quinasas , Melanoma/metabolismo , Melanoma/patología , Ratones , Ratones Transgénicos , Necrosis , Fosfatidilinositol 3-Quinasas/metabolismo , Lesiones Precancerosas , Factor de Transcripción STAT3 , Transducción de Señal , Piel/patología , Neoplasias Cutáneas/metabolismo , Factores de Tiempo , Transactivadores/metabolismo , Transgenes
9.
Arch Biochem Biophys ; 434(1): 3-10, 2005 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-15629102

RESUMEN

Protein tyrosine kinases (PTKs) play key roles in starting the signal transduction network for cellular development and functions. A number of both receptor-type and non-receptor-type PTKs, which are normally at a resting state, are initially activated in association with functions of the cell membrane and membrane rafts. Results of recent studies have suggested that these membrane-associated mechanisms for activation of PTKs consist of the two steps that are under redox control. The first step is activation of cell surface receptors through chemical crosslinkage or aggregation of receptors and membrane rafts, which leads to production of reactive oxygen species (ROS) as second messengers of intracellular signal transduction. The second step involves chemical modification of PTKs at the highly conserved cysteine in the MXXCW motif as a global switch for starting the tyrosine phosphorylation-dependent local switch for activation of the catalytic activity of the enzyme.


Asunto(s)
Membrana Celular/enzimología , Proteínas Tirosina Quinasas/metabolismo , Secuencia de Aminoácidos , Aminoácidos/química , Animales , Catálisis , Humanos , Microdominios de Membrana/enzimología , Modelos Biológicos , Modelos Moleculares , Datos de Secuencia Molecular , Oxidación-Reducción , Conformación Proteica , Proteínas Tirosina Quinasas/química , Proteínas Tirosina Quinasas/genética , Especies Reactivas de Oxígeno/metabolismo , Sistemas de Mensajero Secundario , Homología de Secuencia de Aminoácido , Transducción de Señal , Tirosina/química
10.
Nagoya J Med Sci ; 67(3-4): 59-64, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17375471

RESUMEN

Complete sequencing of the whole genome of humans has revealed a surprisingly small difference between the genomes of humans and higher primates. I here propose that evolution has occurred in living organisms in two steps, first within the genome and then outside the genome. The first step of evolution is based on creation of new information in the genome (DNA), followed by selection after its vertical transmission to individuals of the next generation through reproduction. The second step includes accumulation of a huge amount of information translated into a "linguistic" code by memory and a natural process of computation that creates new patterns of information through thinking in the brain. The created patterns are selected positively or negatively by applying some criteria as to the usefulness for adaptation of humans to nature. When positively selected, the patterns are horizontally transmitted to other brains of a number of individuals, within and also beyond the generation recursively by the use of linguistic codes. This second step of evolution, in conjunction with the evolution of human language itself, has enabled the homo sapiens to attain an enormously high level of cognitive faculty for adaptation of the thought processes to needs in nature at an extraordinarily high speed.


Asunto(s)
Evolución Biológica , Genoma Humano , Humanos , Lenguaje
11.
Eur J Immunol ; 35(1): 86-97, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15593120

RESUMEN

Naive T cells do not proliferate but remain alive in vivo. In contrast, naive T cells rapidly die in an in vitro culture, suggesting that some factors that are present at the sites of naive T cell circulation in vivo but missing in the bovine serum-containing culture medium, are necessary for their survival. The present study was designed to search for such factors. By functional screening of the cDNA library from murine lymph node-derived stromal cells (LNS) that effectively support the survival of naive T cells, we found that nascent polypeptide-associated complex (alpha-NAC) promoted T cell survival. A conditioned medium derived from culture supernatant of Cos7 cells transfected with alpha-NAC gene supported T cell survival, indicating that alpha-NAC induced production of soluble factor(s) that were secreted into the medium. By examining the products that were cloned from a functional screening of the cDNA library from alpha-NAC-transfected NIH3T3 cells but were not detected in that from control vector-transfected cells, galectin-1 was found as a soluble factor in the conditioned medium of the LNS. Our study demonstrates the novel role of galectin-1 as a soluble factor that functions to maintain naive T cell survival without inducing cell proliferation.


Asunto(s)
Galectina 1/farmacología , Linfocitos T/efectos de los fármacos , Animales , Apoptosis/efectos de los fármacos , Secuencia de Bases , Células COS , Bovinos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Medios de Cultivo Condicionados , ADN Complementario/genética , Galectina 1/genética , Galectina 1/metabolismo , Técnicas In Vitro , Activación de Linfocitos , Ratones , Chaperonas Moleculares , Células 3T3 NIH , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacología , Linfocitos T/citología , Linfocitos T/inmunología , Transactivadores/genética , Transactivadores/metabolismo , Transactivadores/farmacología , Transfección , Proteína bcl-X
12.
J Exp Med ; 200(9): 1123-34, 2004 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-15520244

RESUMEN

Regulation of immune system is of paramount importance to prevent immune attacks against self-components. Mice deficient in the interleukin (IL)-2/IL-15 receptor beta chain, CD122, are model animals of such immune attacks and characteristically have a high number of abnormally activated T cells. Here, we show that the transfer of CD8+CD122+ cells into CD122-deficient neonates totally prevented the development of abnormal T cells. Furthermore, recombination activating gene-2-/- mice that received wild-type mice-derived CD8+CD122- cells died within 10 wk after cell transfer, indicating that normal CD8+CD122- cells become dangerously activated T cells in the absence of CD8+CD122+ T cells. CD8+CD122+ cells could control activated CD8+ or CD4+ T cells both in vivo and in vitro. Our results indicate that the CD8+CD122+ population includes naturally occurring CD8+ regulatory T cells that control potentially dangerous T cells.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Homeostasis/inmunología , Receptores de Interleucina-2/inmunología , Subgrupos de Linfocitos T/inmunología , Factores de Edad , Animales , Proteínas de Unión al ADN/inmunología , Citometría de Flujo , Ratones , Ratones Mutantes , Reacción en Cadena de la Polimerasa , Receptores de Interleucina-2/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Subgrupos de Linfocitos T/metabolismo
13.
J Cell Biochem ; 93(1): 162-72, 2004 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-15352173

RESUMEN

Paeoniflorin (PF), isolated from paeony root, has been used as a herbal medicine for more than 1,200 years in China, Korea, and Japan for its anti-allergic, anti-inflammatory, and immunoregulatory effects. In this study, we found that PF induces apoptosis in both murine T-lineage cells and human T-cell leukemia Jurkat cells. This apoptosis was mediated through the reduction of mitochondrial membrane potential, activation of caspase, and fragmentation of DNA. Interestingly, PF induced generation of reactive oxygen species (ROS) and a reducing agent, dithiothreitol (DTT), and a ROS scavenger, N-acetyl cysteine (NAC), successfully attenuated the PF-induced apoptosis. Additionally, PF induced the phosphorylation of three mitogen-activated protein (MAP) family kinases, extracellular signal-regulated kinase, c-Jun amino-terminal kinase (JNK), and p38 MAP kinase. Curcumin, an anti-oxidant and JNK inhibitor, inhibited PF-induced apoptosis, suggesting the possible involvement of curcumin-sensitive JNK or other redox-sensitive elements in PF-induced apoptosis. These results partially explain the action mechanism of PF-containing paeony root as a herbal medicine.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Apoptosis/efectos de los fármacos , Benzoatos/farmacología , Hidrocarburos Aromáticos con Puentes/farmacología , Glucósidos/farmacología , Linfocitos/efectos de los fármacos , Acetilcisteína/farmacología , Animales , Antioxidantes/farmacología , Caspasas/metabolismo , Curcumina/farmacología , Ditiotreitol/farmacología , Activación Enzimática/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Humanos , Células Jurkat/efectos de los fármacos , Células Jurkat/metabolismo , Potenciales de la Membrana/efectos de los fármacos , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Proteínas Quinasas Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Monoterpenos , Oxidación-Reducción , Paeonia/química , Fosforilación/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo
14.
Hear Res ; 195(1-2): 35-40, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15350277

RESUMEN

We report on the cochlea of a novel metallothionein-I (MT)/RFP-RET transgenic mouse model with severe systemic melanosis. Electron microscopy revealed that these transgenic mice possess abundant quantities of melanin in the intermediate cells of the stria vascularis. High performance liquid chromatography analysis indicated that cochleae of these transgenic mice contained about twice as much eumelanin as cochleae of control C57BL/6 mice and that the amount of pheomelanin was approximately equal in these two strains. Auditory brainstem responses at 2, 4, 8, and 16 kHz were not significantly different between transgenic and control mice. This is the first report on a mouse model of overproduction of cochlear eumelanin, and our results suggest that this transgenic mouse is an excellent model for investigating the effects of overexpression of cochlear eumelanin. In addition, we provide evidence that eumelanin overproduction in the cochlea does not affect normal hearing.


Asunto(s)
Cóclea/metabolismo , Modelos Animales de Enfermedad , Melaninas/metabolismo , Melanosis/metabolismo , Metalotioneína/genética , Proteínas Proto-Oncogénicas/genética , Proteínas Tirosina Quinasas Receptoras/genética , Animales , Cromatografía Líquida de Alta Presión , Potenciales Evocados Auditivos del Tronco Encefálico , Melanosis/patología , Melanosis/fisiopatología , Ratones , Ratones Endogámicos , Ratones Transgénicos , Microscopía Electrónica , Proteínas Proto-Oncogénicas c-ret , Índice de Severidad de la Enfermedad , Estría Vascular/metabolismo , Estría Vascular/ultraestructura
15.
Gene ; 336(1): 139-46, 2004 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-15225883

RESUMEN

The GADD34 gene is transcriptionally induced by growth arrest and DNA damage. However, the mechanisms underlying the transcriptional regulation are still unclear. We analyzed the promoter of mouse GADD34 gene and the methylmethane sulfonate (MMS)-induced transcriptional regulation of this gene. By introducing genome mutants, which were linked to the luciferase reporter, into NIH3T3 cells, we defined a 100-bp fragment upstream of the transcriptional initiating site as the minimal promoter of the GADD34 gene. Subsequent study revealed that CRE-binding site located in this minimal promoter was critical for MMS-induced transcription of the GADD34 gene. In vitro binding experiments showed that phosphorylated c-Jun was contained in the CRE/DNA complex. Overexpression of the dominant negative form of c-Jun led to a decrease of MMS-responsive promoter activity. From these results, we conclude that the CRE site of the GADD34 promoter is indispensable to the MMS-responsive cis-element that c-Jun is the essential transcription factor for MMS-stimulated regulation of GADD34 gene expression and that the upstream signaling is dependent on JNK.


Asunto(s)
MAP Quinasa Quinasa 4 , Metilmetanosulfonato/toxicidad , Mutágenos/toxicidad , Proteínas/genética , Transcripción Genética/efectos de los fármacos , Factor de Transcripción Activador 2 , Animales , Antígenos de Diferenciación , Sitios de Unión/genética , Proteínas de Ciclo Celular , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/genética , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Ensayo de Cambio de Movilidad Electroforética , Activación Enzimática/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Immunoblotting , Luciferasas/genética , Luciferasas/metabolismo , Ratones , Quinasas de Proteína Quinasa Activadas por Mitógenos/metabolismo , Mutación , Células 3T3 NIH , Fosforilación/efectos de los fármacos , Regiones Promotoras Genéticas/genética , Unión Proteica , Proteína Fosfatasa 1 , Proteínas Proto-Oncogénicas c-jun/genética , Proteínas Proto-Oncogénicas c-jun/metabolismo , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Elementos de Respuesta/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Transfección
16.
FEBS Lett ; 567(2-3): 171-4, 2004 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-15178317

RESUMEN

Okadaic acid (OA) is a protein phosphatase (PP) inhibitor and induces hyperphosphorylation of p53. We investigated whether the inhibition of PP1 by OA promotes the phosphorylation of the serine 15 of p53. In vitro dephosphorylation assay showed that PP1 dephosphorylated ultraviolet C (UVC)-induced phospho-ser15 of p53, and that OA treatment inhibited it. One of the PP1 regulators, growth arrest and DNA damage 34 (GADD34), disturbed PP1 binding with p53, interfered with the dephosphorylation of p53 and increased the amount of phospho-p53 after UVC-treatment. This report provides the first evidence that PP1, but not PP2A, dephosphorylates phospho-serine 15 of p53.


Asunto(s)
Daño del ADN/fisiología , Fosfoproteínas Fosfatasas/metabolismo , Fosfoserina/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Animales , Antígenos de Diferenciación , Antígenos Transformadores de Poliomavirus/farmacología , Proteínas de Ciclo Celular , Línea Celular , Inhibidor p21 de las Quinasas Dependientes de la Ciclina , Ciclinas/metabolismo , Daño del ADN/efectos de la radiación , Embrión de Mamíferos/citología , Inhibidores Enzimáticos/farmacología , Factor 2 Eucariótico de Iniciación/metabolismo , Fibroblastos/citología , Humanos , Metilmetanosulfonato/farmacología , Ratones , Ratones Noqueados , Ácido Ocadaico/farmacología , Fosfoproteínas Fosfatasas/antagonistas & inhibidores , Fosforilación , Proteína Fosfatasa 1 , Proteína Fosfatasa 2 , Proteínas/genética , Proteínas/metabolismo , Proteína p53 Supresora de Tumor/química , Proteína p53 Supresora de Tumor/genética , Rayos Ultravioleta
17.
Immunology ; 112(1): 64-71, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15096185

RESUMEN

We previously developed a transgenic mouse line into which a rabbit protein kinase Calpha (PKCalpha) gene fused to a human CD2 promoter/enhancer was introduced, and we found that immunosenescence was facilitated in these transgenic mice. In this study, we found that along with age-dependent increase in the level of protein expression of PKCalpha and its translocation to the membrane, activated T cells became less sensitive to apoptosis-inducing anti-Fas antibody. The capacity of T cells to express Fas antigen on their surfaces in response to anti-CD3 and interleukin-2 was impaired in PKCalpha-transgenic mice of relatively advanced age, although background Fas expression levels on T cells from those mice were high. We then found that out of proportion to a high level of cell surface Fas expression the density of cholera toxin B (CTx)-binding raft elements decreased in PKCalpha-transgenic mice of relatively advanced age and to a lesser extent in normal mice of advanced age. Correspondingly, the expression level of raft-associating Lck was decreased in these mice. These findings suggest for the first time that immunosenescence of T cells involves a decrease in density of cell surface CTx-binding raft elements, which might underlie a deterioration in T-cell signal pathway for either cell death or cell activation.


Asunto(s)
Envejecimiento/inmunología , Apoptosis/inmunología , Microdominios de Membrana/inmunología , Linfocitos T/inmunología , Receptor fas/inmunología , Animales , Células Cultivadas , Toxina del Cólera/metabolismo , Modelos Animales de Enfermedad , Tolerancia Inmunológica/inmunología , Interleucina-2/inmunología , Activación de Linfocitos/inmunología , Microdominios de Membrana/metabolismo , Ratones , Ratones Transgénicos , Proteína Quinasa C/genética , Proteína Quinasa C/inmunología , Proteína Quinasa C-alfa , Transducción de Señal/inmunología
18.
Cancer Res ; 64(4): 1496-501, 2004 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-14973052

RESUMEN

Tumor antigen-reactive T cells can be detected in a large proportion of melanoma patients, but their efficacy on tumor control in vivo remains unclear. On the other hand, vitiligo, a skin disorder characterized by patchy depigmented macules, may occur spontaneously or after antitumor therapies. Moreover, vitiligo is significantly associated with positive clinical response, but the mechanism is not understood. Therefore, the establishment of a relevant animal model in which melanoma and vitiligo spontaneously develop stepwise may be useful for better understanding of the parameters involved in the destruction of both benign and malignant melanocytes. In a previous work, we established a mouse model for melanoma in which MT/ret transgenic mice express the ret oncogene fused to the metallothionein promoter. Here we report that melanoma leads to spontaneous vitiligo. We further investigate, for the first time in this model, the natural antitumor T-cell response and evaluate the role of cellular immunity in the development of the disease. Interestingly, the occurrence of spontaneous tumor nodules in MT/ret mice with melanoma-associated vitiligo is significantly delayed when compared in melanoma mice without vitiligo. Moreover, a significant proportion of mice with melanoma-associated vitiligo resisted a challenge with syngeneic melanoma cells in contrast to animals without vitiligo. Our results confirm that vitiligo is associated with clinical benefit and further demonstrate the crucial role of CD8+ T cells for tumor control in melanoma-associated vitiligo.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Modelos Animales de Enfermedad , Melanoma/inmunología , Vitíligo/etiología , Animales , Interferón gamma/biosíntesis , Metales Pesados/toxicidad , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Transgénicos , Proteínas Oncogénicas/genética , Proteínas Proto-Oncogénicas c-ret , Proteínas Tirosina Quinasas Receptoras/genética
19.
Mol Pharmacol ; 65(3): 778-87, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-14978257

RESUMEN

Methylglyoxal (MG) is an endogenous metabolite that increases in the blood and tissues of diabetic patients and is believed to be linked to the development of chronic complications of diabetes. We showed previously that Jurkat cells treated with MG rapidly undergo apoptosis via c-Jun N-terminal kinase (JNK) activation. In this study, we examined whether phorbol 12-myristate 13-acetate (PMA) can prevent MG-induced apoptosis in Jurkat cells. The results showed the following: 1) PMA can prevent MG-induced apoptosis; 2) triggering of this antiapoptotic signal depends on the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (ERK) pathway; 3) PMA inhibits MG-induced activation of caspase-3 and caspase-9, release of cytochrome c, and decline of mitochondrial membrane potential, but it does not affect MG-induced JNK activation; 4) the ERK pathway modulates outer mitochondrial membrane permeability and regulates the mitochondrial death machinery; and 5) activated ERK prevents JNK-induced leakage of cytochrome c from isolated mitochondria. Taken together, these results suggest that PMA-induced ERK activation can protect Jurkat cells from methylglyoxal-induced apoptosis and that activated ERK exerts its antiapoptotic effects on mitochondria by inhibiting activated JNK-induced permeabilization of the outer mitochondrial membrane.


Asunto(s)
Apoptosis , Citocromos c/metabolismo , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Piruvaldehído/farmacología , Acetato de Tetradecanoilforbol/farmacología , Animales , Caspasa 8 , Caspasas/metabolismo , Interacciones Farmacológicas , Humanos , Proteínas Quinasas JNK Activadas por Mitógenos , Células Jurkat , Sistema de Señalización de MAP Quinasas/fisiología , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/enzimología , Bazo/citología
20.
Cancer Res ; 64(3): 801-6, 2004 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-14871802

RESUMEN

The role of c-Kit in the development of melanoma was studied in line 304/B6 of RET-transgenic mice, in which melanoma spontaneously develops. In Wv/Wv-RET (304/B6)-transgenic mice, in which c-Kit function was severely impaired, development of melanoma was strongly suppressed. Although 31 of the 44 original RET-transgenic mice died of rapidly growing melanoma within 12 months after birth, only 8 of the 44 Wv/Wv-RET-transgenic mice developed slowly growing melanocytic tumors with a greatly prolonged mean tumor-free period, 2 of which died of melanoma at a late stage. Even Wv/+-RET-transgenic mice had a clearly prolonged tumor-free period and definitely reduced frequency (6 of 61) of tumor death within 12 months after birth. Melanin production in the skin of these mice was not strongly impaired, suggesting that c-Kit affects the development of melanomas in these mice with only minor effects in melanin production. c-Kit expression in skin soon after birth was promoted in RET-transgenic mice, and c-Kit was expressed at high levels at the benign but not malignant stage of the tumor. A single injection of anti-c-Kit antibody (ACK2) into RET-transgenic mice soon after birth caused a surprisingly long-lasting suppression of development of melanoma, greatly prolonging the tumor-free period, and none of the 28 ACK2-treated RET-transgenic mice died from tumors at 12 months of age. The c-Kit function needed for melanin production was also suppressed for an unusually long time in ACK2-treated, RET-transgenic mice. These results suggest that c-Kit can be a unique target molecule for melanoma treatment.


Asunto(s)
Anticuerpos Monoclonales/farmacología , Inmunización Pasiva/métodos , Melanoma Experimental/inmunología , Melanoma Experimental/prevención & control , Proteínas Proto-Oncogénicas c-kit/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Modelos Animales de Enfermedad , Proteínas de Drosophila/genética , Melanoma Experimental/genética , Ratones , Ratones Transgénicos , Proteínas Proto-Oncogénicas c-kit/biosíntesis , Proteínas Proto-Oncogénicas c-kit/genética , Proteínas Proto-Oncogénicas c-ret , Proteínas Tirosina Quinasas Receptoras/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA